<?xml version="1.0" encoding="ISO-8859-1" standalone="yes"?>
<CourseDefinition>
  <Schema>
    <Version>3.0</Version>
    <Date>20120717</Date>
  </Schema>
  <Details>
    <RegimId>NRB-5666</RegimId>
    <Name>Rituximab-Cyklofosfamid-Dexametason 14 dagar, kur 2 osv, underhållsdos</Name>
    <ShortName/>
    <MajorVersion>1</MajorVersion>
    <MinorVersion>2</MinorVersion>
    <DefinitionStatus>COMPLETED</DefinitionStatus>
    <PatientMaxSurface/>
    <CourseICDZCode>NONE</CourseICDZCode>
    <CourseAUC>0.00</CourseAUC>
    <MaxAge/>
    <CycleLength>14</CycleLength>
    <ValidForAllDiagnoses/>
    <IsStudyDefinition>NO</IsStudyDefinition>
    <PhysicianComment>Emetogenicitet:Medel.\n\nDiagnoskod: D59.\n\nKurintervall: 14 dagar.\n\nBehandlingsavsikt: Remissionssyftande.\n\n</PhysicianComment>
    <NurseComment/>
    <PharmacistComment/>
    <PatientComment/>
    <ExternalDocumentation/>
    <ExternalPhysicianDoc>https://kunskapsbanken.cancercentrum.se/redirect/regim/5666</ExternalPhysicianDoc>
    <ExternalNurseDoc>https://kunskapsbanken.cancercentrum.se/redirect/regim/5666</ExternalNurseDoc>
    <ExternalPharmacistDoc/>
    <ExternalPatientDoc/>
    <Rounding/>
    <HasSteps/>
  </Details>
  <Miscellaneous>
    <OriginOfExport>Regimbiblioteket</OriginOfExport>
    <IsAuthorized/>
    <CommittedBy/>
    <CreatedBy/>
    <CreatedDate>20260211</CreatedDate>
  </Miscellaneous>
  <Diagnoses>
    <Diagnose Text="Kronisk lymfatisk leukemi (KLL)"/>
  </Diagnoses>
  <Protocols/>
  <AdditionalInformation/>
  <Days>
    <Day Number="1">
      <Details>
        <Name/>
        <ConfirmationMandatory>NO</ConfirmationMandatory>
        <Comment/>
      </Details>
      <CriticalParameters/>
      <Lines>
        <Line Number="1">
          <Details>
            <Type>ANTIDOTE</Type>
            <Route>PO</Route>
            <InfusionHours>0</InfusionHours>
            <InfusionMinutes>0</InfusionMinutes>
            <ProductionBy>WARD</ProductionBy>
            <RelationType>NONE</RelationType>
          </Details>
          <Substance Name="dexametason">
            <Dose Max="">40</Dose>
            <Steps>0</Steps>
            <Unit>MG</Unit>
            <Calculation>STANDARD</Calculation>
          </Substance>
          <Fluid Name="Ej aktuellt">
            <Volume/>
            <Unit/>
            <Calculation/>
          </Fluid>
          <Comments/>
        </Line>
        <Line Number="2">
          <Details>
            <Type>ANTIDOTE</Type>
            <Route>PO</Route>
            <InfusionHours>0</InfusionHours>
            <InfusionMinutes>0</InfusionMinutes>
            <ProductionBy>WARD</ProductionBy>
            <RelationType>NONE</RelationType>
          </Details>
          <Substance Name="Antiemetika">
            <Dose Max="">0</Dose>
            <Unit>MG</Unit>
            <Calculation>STANDARD</Calculation>
          </Substance>
          <Fluid Name="Ej aktuellt">
            <Volume/>
            <Unit/>
            <Calculation/>
          </Fluid>
          <Comments>
            <Comment Text="Premedicinering för rituximab"/>
          </Comments>
        </Line>
        <Line Number="3">
          <Details>
            <Type>FLUID</Type>
            <Route>IVINF</Route>
            <InfusionHours>0</InfusionHours>
            <InfusionMinutes>0</InfusionMinutes>
            <ProductionBy>WARD</ProductionBy>
            <RelationType>NONE</RelationType>
          </Details>
          <Fluid Name="Natriumklorid 9 mg/ml">
            <Volume>250</Volume>
            <Steps>0</Steps>
            <Unit>ML</Unit>
            <Calculation/>
          </Fluid>
          <Comments>
            <Comment Text="Spoldropp att fördelas mellan och efter sista läkemedlet"/>
          </Comments>
        </Line>
        <Line Number="4">
          <Details>
            <Type>ANTIDOTE</Type>
            <Route>PO</Route>
            <InfusionHours>0</InfusionHours>
            <InfusionMinutes>0</InfusionMinutes>
            <ProductionBy>WARD</ProductionBy>
            <RelationType>NONE</RelationType>
          </Details>
          <Substance Name="Antiemetika">
            <Dose Max="">0</Dose>
            <Unit>MG</Unit>
            <Calculation>STANDARD</Calculation>
          </Substance>
          <Fluid Name="Ej aktuellt">
            <Volume/>
            <Unit/>
            <Calculation/>
          </Fluid>
          <Comments>
            <Comment Text="Tablett/Injektion Antiemetika"/>
          </Comments>
        </Line>
        <Line Number="5">
          <Details>
            <Type>SUBSTANCE</Type>
            <Route>IVINF</Route>
            <InfusionHours>0</InfusionHours>
            <InfusionMinutes>30</InfusionMinutes>
            <ProductionBy>PHARMACY</ProductionBy>
            <RelationType>NONE</RelationType>
          </Details>
          <Substance Name="rituximab">
            <Dose Max="">375</Dose>
            <Steps>0</Steps>
            <Unit>MG</Unit>
            <Calculation>SURFACE</Calculation>
          </Substance>
          <Fluid Name="Natriumklorid 9 mg/ml">
            <Volume>500</Volume>
            <Steps>0</Steps>
            <Unit>ML</Unit>
            <Calculation/>
          </Fluid>
          <Comments/>
        </Line>
        <Line Number="6">
          <Details>
            <Type>SUBSTANCE</Type>
            <Route>IVINF</Route>
            <InfusionHours>0</InfusionHours>
            <InfusionMinutes>30</InfusionMinutes>
            <ProductionBy>PHARMACY</ProductionBy>
            <RelationType>NONE</RelationType>
          </Details>
          <Substance Name="cyklofosfamidmonohydrat">
            <Dose Max="">1000</Dose>
            <Steps>0</Steps>
            <Unit>MG</Unit>
            <Calculation>STANDARD</Calculation>
          </Substance>
          <Fluid Name="Natriumklorid 9 mg/ml">
            <Volume>250</Volume>
            <Steps>0</Steps>
            <Unit>ML</Unit>
            <Calculation/>
          </Fluid>
          <Comments/>
        </Line>
      </Lines>
    </Day>
  </Days>
</CourseDefinition>
